Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/12571
ROLE OF CD8+ T CELLS IN TRIGGERING REVERSAL REACTION IN HIV/LEPROSY PATIENTS
Author
Affilliation
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Abstract
It has been reported that the initiation of highly active anti-retroviral
therapy (HAART) is associated with the development of reversal reaction
(RR) in co-infected HIV/leprosy patients. Nevertheless, the impact of HIV
and HAART on the cellular immune response to Mycobacterium leprae
(ML) remains unknown. In the present study, we observed that ex vivo
peripheral blood mononuclear cells (PBMCs) of both RR and RR/HIV
patients presented increased percentages of activated CD4+ T cells when
compared with the healthy individuals (HC) group. The frequency of
CD8+ CD38+ cells increased in the PBMCs of RR/HIV patients but not in
RR patients when compared with the HC group. Both RR and RR/HIV
skin lesion cells presented similar percentages of activated CD4+ cells, but
the numbers of activated CD8+ cells were higher in RR/HIV in comparison
to the RR group. The frequency of interferon-c-producing cells was
high in response to ML regardless of HIV co-infection. In ML-stimulated
cells, there was an increase in central memory CD4+ T-cell frequencies in
the RR and RR/HIV groups, but an increase in central memory CD8+ Tcell
frequency was only observed in the RR/HIV group. ML increased
granzyme B+ effector memory CD8+ T-cell frequencies in the RR/HIV
PBMCs, but not in the HC and RR groups. Our data suggest that the
increased expression of effector memory CD8+ T cells, together with
greater perforin/granzyme B production, could be an additional mechanism
leading to the advent of RR in co-infected patients. Moreoever, this
increased expression may explain the severity of RR occurring in these
patients.
Share